SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biopower Operations Corp. – ‘10-Q’ for 8/31/22 – ‘JSON’

On:  Friday, 12/2/22, at 3:23pm ET   ·   For:  8/31/22   ·   Accession #:  1493152-22-34278   ·   File #:  333-172139

Previous ‘10-Q’:  ‘10-Q’ on 7/15/22 for 5/31/22   ·   Next:  ‘10-Q/A’ on 12/14/22 for 8/31/22   ·   Latest:  ‘10-Q’ on 8/22/23 for 5/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/02/22  Biopower Operations Corp.         10-Q        8/31/22   40:3.8M                                   M2 Compliance LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    893K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
10: R1          Cover                                               HTML     62K 
11: R2          Consolidated Balance Sheets                         HTML     97K 
12: R3          Consolidated Balance Sheets (Parenthetical)         HTML     36K 
13: R4          Consolidated Statements of Operations               HTML     63K 
14: R5          Consolidated Statements of Cash Flows               HTML     83K 
15: R6          Consolidated Statements of Changes in               HTML     82K 
                Stockholders' Deficit (Unaudited)                                
16: R7          Organization                                        HTML     41K 
17: R8          Summary of Significant Accounting Policies          HTML     56K 
18: R9          Notes Payable and Convertible Debt                  HTML     51K 
19: R10         Related Party Transactions                          HTML     69K 
20: R11         Senior Promissory Note - related party              HTML     21K 
21: R12         Stockholders? deficit                               HTML     48K 
22: R13         Commitments and Contingencies                       HTML     35K 
23: R14         Subsequent Events                                   HTML     21K 
24: R15         Summary of Significant Accounting Policies          HTML     92K 
                (Policies)                                                       
25: R16         Notes Payable and Convertible Debt (Tables)         HTML     21K 
26: R17         Related Party Transactions (Tables)                 HTML     18K 
27: R18         Organization (Details Narrative)                    HTML     64K 
28: R19         Summary of Significant Accounting Policies          HTML     79K 
                (Details Narrative)                                              
29: R20         Schedule of Notes Payable (Details)                 HTML     30K 
30: R21         Notes Payable and Convertible Debt (Details         HTML     63K 
                Narrative)                                                       
31: R22         Schedule of Amount Owed on Prepayment of Diagonal   HTML     21K 
                Lending Note (Details)                                           
32: R23         Related Party Transactions (Details Narrative)      HTML    148K 
33: R24         Senior Promissory Note - related party (Details     HTML     27K 
                Narrative)                                                       
34: R25         Stockholders? deficit (Details Narrative)           HTML    118K 
35: R26         Commitments and Contingencies (Details Narrative)   HTML     49K 
38: XML         IDEA XML File -- Filing Summary                      XML     64K 
36: XML         XBRL Instance -- from10-q_htm                        XML    807K 
37: EXCEL       IDEA Workbook of Financial Reports                  XLSX     85K 
 6: EX-101.CAL  Inline XBRL Taxonomy Extension Calculation           XML     87K 
                Linkbase Document -- bopo-20220831_cal                           
 7: EX-101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase   XML    451K 
                Document -- bopo-20220831_def                                    
 8: EX-101.LAB  Inline XBRL Taxonomy Extension Label Linkbase        XML    672K 
                Document -- bopo-20220831_lab                                    
 9: EX-101.PRE  Inline XBRL Taxonomy Extension Presentation          XML    541K 
                Linkbase Document -- bopo-20220831_pre                           
 5: EX-101.SCH  Inline XBRL Taxonomy Extension Schema Document --    XSD     92K 
                bopo-20220831                                                    
39: JSON        XBRL Instance as JSON Data -- MetaLinks              255±   353K 
40: ZIP         XBRL Zipped Folder -- 0001493152-22-034278-xbrl      Zip    175K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"instance":  {
    "from10-q.htm":  {
        "axisCustom":  0,
        "axisStandard":  20,
        "contextCount":  186,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "bopo-20220831_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "bopo-20220831_def.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "from10-q.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "bopo-20220831_lab.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "bopo-20220831_pre.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "bopo-20220831.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
                    "https://xbrl.sec.gov/country/2022/country-2022.xsd",
                    "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
                    ]
                }
            },
        "elementCount":  363,
        "entityCount":  1,
        "hidden":  {
            "http://biopowercorp.com/20220831":  21,
            "http://fasb.org/us-gaap/2022":  121,
            "http://xbrl.sec.gov/dei/2022":  4,
            "total":  146
            },
        "keyCustom":  29,
        "keyStandard":  161,
        "memberCustom":  43,
        "memberStandard":  15,
        "nsprefix":  "BOPO",
        "nsuri":  "http://biopowercorp.com/20220831",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "00000001 - Document - Cover",
                "role":  "http://biopowercorp.com/role/Cover",
                "shortName":  "Cover",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000010 - Disclosure - Related Party Transactions",
                "role":  "http://biopowercorp.com/role/RelatedPartyTransactions",
                "shortName":  "Related Party Transactions",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "BOPO:SeniorPromissoryNoteRelatedPartyDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000011 - Disclosure - Senior Promissory Note \u2013 related party",
                "role":  "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedParty",
                "shortName":  "Senior Promissory Note \u2013 related party",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "BOPO:SeniorPromissoryNoteRelatedPartyDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000012 - Disclosure - Stockholders\u2019 deficit",
                "role":  "http://biopowercorp.com/role/StockholdersDeficit",
                "shortName":  "Stockholders\u2019 deficit",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000013 - Disclosure - Commitments and Contingencies",
                "role":  "http://biopowercorp.com/role/CommitmentsAndContingencies",
                "shortName":  "Commitments and Contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000014 - Disclosure - Subsequent Events",
                "role":  "http://biopowercorp.com/role/SubsequentEvents",
                "shortName":  "Subsequent Events",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConsolidationPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000015 - Disclosure - Summary of Significant Accounting Policies (Policies)",
                "role":  "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
                "shortName":  "Summary of Significant Accounting Policies (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConsolidationPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDebtTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000016 - Disclosure - Notes Payable and Convertible Debt (Tables)",
                "role":  "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtTables",
                "shortName":  "Notes Payable and Convertible Debt (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDebtTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000017 - Disclosure - Related Party Transactions (Tables)",
                "role":  "http://biopowercorp.com/role/RelatedPartyTransactionsTables",
                "shortName":  "Related Party Transactions (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2021-11-30",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000018 - Disclosure - Organization (Details Narrative)",
                "role":  "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                "shortName":  "Organization (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-06-282021-06-29_us-gaap_SeriesCPreferredStockMember",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:ConversionOfStockSharesConverted1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RetainedEarningsAccumulatedDeficit",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000019 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
                "role":  "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                "shortName":  "Summary of Significant Accounting Policies (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:CommonStockParOrStatedValuePerShare",
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2021-11-30",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000002 - Statement - Consolidated Balance Sheets",
                "role":  "http://biopowercorp.com/role/BalanceSheets",
                "shortName":  "Consolidated Balance Sheets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:AccountsReceivableNetCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDebtTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NotesPayable",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000020 - Disclosure - Schedule of Notes Payable (Details)",
                "role":  "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails",
                "shortName":  "Schedule of Notes Payable (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDebtTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31_custom_DemandLoansMember",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:NotesPayable",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDebtTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NotesPayable",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000021 - Disclosure - Notes Payable and Convertible Debt (Details Narrative)",
                "role":  "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                "shortName":  "Notes Payable and Convertible Debt (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2021-11-30",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:InterestPayableCurrentAndNoncurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31_custom_PrepaymentPeriodOneMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "BOPO:DebtInstrumentPrepaymentPercentage",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000022 - Disclosure - Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details)",
                "role":  "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails",
                "shortName":  "Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31_custom_PrepaymentPeriodOneMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "BOPO:DebtInstrumentPrepaymentPercentage",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2015-07-28",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentInterestRateStatedPercentage",
                    "reportCount":  1,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000023 - Disclosure - Related Party Transactions (Details Narrative)",
                "role":  "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                "shortName":  "Related Party Transactions (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2021-11-30",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:InterestPayableCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "BOPO:SeniorPromissoryNoteRelatedPartyDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2021-06-29_custom_ChinaEnergyPartnersNoteAmendmentMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000024 - Disclosure - Senior Promissory Note \u2013 related party (Details Narrative)",
                "role":  "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                "shortName":  "Senior Promissory Note \u2013 related party (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "BOPO:SeniorPromissoryNoteRelatedPartyDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2021-06-29_custom_ChinaEnergyPartnersNoteAmendmentMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-06-012021-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockIssuedDuringPeriodValueIssuedForServices",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000025 - Disclosure - Stockholders\u2019 deficit (Details Narrative)",
                "role":  "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                "shortName":  "Stockholders\u2019 deficit (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:PreferredStockParOrStatedValuePerShare",
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2021-11-30_us-gaap_SeriesAPreferredStockMember",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2022-06-252022-06-26_custom_RestrictedCommonStockMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000026 - Disclosure - Commitments and Contingencies (Details Narrative)",
                "role":  "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                "shortName":  "Commitments and Contingencies (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-06-26_custom_PIPAgreementMember",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "BOPO:GrossSalesCustomaryPercentage",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscountCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
                "role":  "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                "shortName":  "Consolidated Balance Sheets (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscountCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2022-06-012022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000004 - Statement - Consolidated Statements of Operations",
                "role":  "http://biopowercorp.com/role/StatementsOfOperations",
                "shortName":  "Consolidated Statements of Operations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2022-06-012022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000005 - Statement - Consolidated Statements of Cash Flows",
                "role":  "http://biopowercorp.com/role/StatementsOfCashFlows",
                "shortName":  "Consolidated Statements of Cash Flows",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2020-12-012021-08-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2020-11-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000006 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)",
                "role":  "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                "shortName":  "Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "AsOf2020-11-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000007 - Disclosure - Organization",
                "role":  "http://biopowercorp.com/role/Organization",
                "shortName":  "Organization",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000008 - Disclosure - Summary of Significant Accounting Policies",
                "role":  "http://biopowercorp.com/role/SummaryOfSignificantAccountingPolicies",
                "shortName":  "Summary of Significant Accounting Policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000009 - Disclosure - Notes Payable and Convertible Debt",
                "role":  "http://biopowercorp.com/role/NotesPayableAndConvertibleDebt",
                "shortName":  "Notes Payable and Convertible Debt",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "from10-q.htm",
                    "contextRef":  "From2021-12-01to2022-08-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  60,
        "tag":  {
            "BOPO_AdditionalBorrowing":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additional borrowing.",
                            "label":  "AdditionalBorrowing",
                            "verboseLabel":  "Debt instrument, principal amount"
                            }
                        }
                    },
                "localname":  "AdditionalBorrowing",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_BaruchHalpernMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Baruch Halpern [Member]"
                            }
                        }
                    },
                "localname":  "BaruchHalpernMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_BioPowerCorporationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Bio power corporation [Member]",
                            "label":  "BioPower Corporation [Member]"
                            }
                        }
                    },
                "localname":  "BioPowerCorporationMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_BonnieNelsonMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Bonnie Nelson [Member]"
                            }
                        }
                    },
                "localname":  "BonnieNelsonMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_CanadianInvestorMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Canadian investor [Member]",
                            "label":  "Canadian Investor [Member]"
                            }
                        }
                    },
                "localname":  "CanadianInvestorMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ChiefExecutiveOfficerAndDirectorMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Chief Executive Officer And Director [Member]",
                            "label":  "Chief Executive Officer and Director [Member]"
                            }
                        }
                    },
                "localname":  "ChiefExecutiveOfficerAndDirectorMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ChinaEnergyPartnersLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "China Energy Partners LLC [Member]",
                            "label":  "China Energy Partners LLC [Member]"
                            }
                        }
                    },
                "localname":  "ChinaEnergyPartnersLLCMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ChinaEnergyPartnersNoteAmendmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "China Energy Partners Note Amendment [Member]"
                            }
                        }
                    },
                "localname":  "ChinaEnergyPartnersNoteAmendmentMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_CommonStockOwedValue":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock owed value.",
                            "label":  "Common Stock owed"
                            }
                        }
                    },
                "localname":  "CommonStockOwedValue",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_CommonStockPayableMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common Stock Payable [Member]",
                            "label":  "Common Stock Payable [Member]"
                            }
                        }
                    },
                "localname":  "CommonStockPayableMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ConsultantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ConvertibleDebtAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Debt Agreement [Member]",
                            "label":  "Convertible Debt Agreement [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtAgreementMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ConvertibleDebtRelatedPartiesClassifiedCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible debt related parties classified current.",
                            "label":  "Convertible debt - related parties,"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtRelatedPartiesClassifiedCurrent",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_ConvertibleDebtVariablePricedConversionCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible debt variable priced conversion current.",
                            "label":  "Convertible debt vsriable priced converstion, not of discount of $111,213"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtVariablePricedConversionCurrent",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_ConvertibleNotesPayableToRelatedPartiesNonCurrent":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible notes payable to related parties non current.",
                            "label":  "Convertible notes payable to related parties"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableToRelatedPartiesNonCurrent",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_DebtInstrumentPrepaymentPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt prepayment percentage.",
                            "label":  "Prepayment, rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentPrepaymentPercentage",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "BOPO_DebtTransferAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt transfer amount"
                            }
                        }
                    },
                "localname":  "DebtTransferAmount",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_DemandLoanAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Demand Loan Agreements [Member]",
                            "label":  "Demand Loan Agreements [Member]"
                            }
                        }
                    },
                "localname":  "DemandLoanAgreementsMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_DemandLoansMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Demand Loans [Member]",
                            "label":  "Demand Loans [Member]"
                            }
                        }
                    },
                "localname":  "DemandLoansMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_DigitalArtMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Digital Art [Member]"
                            }
                        }
                    },
                "localname":  "DigitalArtMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_DirectorOfBusinessStrategyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Director Of Business Strategy [Member]",
                            "label":  "Director Of Business Strategy [Member]"
                            }
                        }
                    },
                "localname":  "DirectorOfBusinessStrategyMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_DisclosureSeniorPromissoryNoteRelatedPartyAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Senior Promissory Note Related Party"
                            }
                        }
                    },
                "localname":  "DisclosureSeniorPromissoryNoteRelatedPartyAbstract",
                "nsuri":  "http://biopowercorp.com/20220831",
                "xbrltype":  "stringItemType"
                },
            "BOPO_ExclusiveLicenseOptionsYearFiveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exclusive License Options Year Five [Member]"
                            }
                        }
                    },
                "localname":  "ExclusiveLicenseOptionsYearFiveMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ExclusiveLicenseOptionsYearOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exclusive License Options Year One [Member]"
                            }
                        }
                    },
                "localname":  "ExclusiveLicenseOptionsYearOneMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_FTZExchangeLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "FTZ Exchange LLC [Member]",
                            "label":  "FTZ Exchange LLC [Member]"
                            }
                        }
                    },
                "localname":  "FTZExchangeLLCMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_GoingConcernPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Going Concern [Policy Text Block]",
                            "label":  "Going Concern"
                            }
                        }
                    },
                "localname":  "GoingConcernPolicyTextBlock",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "BOPO_GrossSalesCustomaryPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross sales customary percentage.",
                            "label":  "Gross sales percentage"
                            }
                        }
                    },
                "localname":  "GrossSalesCustomaryPercentage",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "pureItemType"
                },
            "BOPO_HyFiMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "HyFi [Member]",
                            "label":  "HyFi [Member]"
                            }
                        }
                    },
                "localname":  "HyFiMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_HyFiTokensMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "HyFi Tokens [Member]",
                            "label":  "HyFi Tokens [Member]"
                            }
                        }
                    },
                "localname":  "HyFiTokensMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_IncreaseDecreaseInLongTermDebt":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase decrease in long term debt.",
                            "label":  "Increase decrease in long term debt"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInLongTermDebt",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_LenderMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lender [Member]",
                            "label":  "Lender [Member]"
                            }
                        }
                    },
                "localname":  "LenderMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_NFTsReceivedFromAcquisition":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "NFTs received from acquisition.",
                            "label":  "NFTs received from acquisition"
                            }
                        }
                    },
                "localname":  "NFTsReceivedFromAcquisition",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "integerItemType"
                },
            "BOPO_NoncashCommonStockIssuedForAccruedSalaryRelatedParty":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncash common stock issued for accrued salary - related party.",
                            "label":  "Common stock issued for accrued salary - related party"
                            }
                        }
                    },
                "localname":  "NoncashCommonStockIssuedForAccruedSalaryRelatedParty",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_NoncashCommonStockIssuedForAccruedSeverance":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncash common stock issued for accrued severance.",
                            "label":  "Common stock issued for accrued severance"
                            }
                        }
                    },
                "localname":  "NoncashCommonStockIssuedForAccruedSeverance",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_NotesPayableAndConvertibleDebtMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Notes Payable and Convertible Debt [Member]",
                            "label":  "Notes Payable and Convertible Debt [Member]"
                            }
                        }
                    },
                "localname":  "NotesPayableAndConvertibleDebtMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_NotesPayableSeniorSecuredRelatedParty":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Notes payable senior secured related party.",
                            "label":  "Notes payable Senior secured - related party"
                            }
                        }
                    },
                "localname":  "NotesPayableSeniorSecuredRelatedParty",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_NumberOfAssets":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of assets.",
                            "label":  "Number of assets"
                            }
                        }
                    },
                "localname":  "NumberOfAssets",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "integerItemType"
                },
            "BOPO_NumberOfTokensIssuedToPurchaseAssets":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of tokens issued to purchase assets.",
                            "label":  "Number of tokens, issued"
                            }
                        }
                    },
                "localname":  "NumberOfTokensIssuedToPurchaseAssets",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "integerItemType"
                },
            "BOPO_OneCustomerMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "One Customer [Member]",
                            "label":  "One Customer [Member]"
                            }
                        }
                    },
                "localname":  "OneCustomerMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_PIPAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "P I P Agreement [Member]"
                            }
                        }
                    },
                "localname":  "PIPAgreementMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_PrepaymentPeriodOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "May 31, 2022 to July 30, 2022 [Member]",
                            "label":  "May 31, 2022 to July 30, 2022 [Member]"
                            }
                        }
                    },
                "localname":  "PrepaymentPeriodOneMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_PrepaymentPeriodThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "October 29, 2022 to November 27, 2022 [Member]",
                            "label":  "October 29, 2022 to November 27, 2022 [Member]"
                            }
                        }
                    },
                "localname":  "PrepaymentPeriodThreeMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_PrepaymentPeriodTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "July 31, 2022 to October 28, 2022 [Member]",
                            "label":  "July 31, 2022 to October 28, 2022 [Member]"
                            }
                        }
                    },
                "localname":  "PrepaymentPeriodTwoMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_PurchaseOfVaultsDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Purchase of vaults description.",
                            "label":  "Purchase of vaults, description"
                            }
                        }
                    },
                "localname":  "PurchaseOfVaultsDescription",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "BOPO_ReclassificationOfAccruedCompensationToNotesPayableMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reclassification Of Accrued Compensation To Notes Payable [Member]",
                            "label":  "Reclassification of Accrued Compensation To Notes Payable [Member]"
                            }
                        }
                    },
                "localname":  "ReclassificationOfAccruedCompensationToNotesPayableMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_RedemptionAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Redemption Agreement [Member]",
                            "label":  "Redemption Agreement [Member]"
                            }
                        }
                    },
                "localname":  "RedemptionAgreementMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ReductionInLiabilityShareIssurance":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reduction in liability share issurance.",
                            "label":  "Reduction in liability insurance"
                            }
                        }
                    },
                "localname":  "ReductionInLiabilityShareIssurance",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_RelatedPartiesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related Parties [Member]",
                            "label":  "Related Parties [Member]"
                            }
                        }
                    },
                "localname":  "RelatedPartiesMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_RestrictedCommonStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restricted Common Stock [Member]"
                            }
                        }
                    },
                "localname":  "RestrictedCommonStockMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_RobertKohnMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Robert Kohn [Member]",
                            "label":  "Robert Kohn [Member]"
                            }
                        }
                    },
                "localname":  "RobertKohnMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_SaleOfTokensMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale Of Tokens [Member]"
                            }
                        }
                    },
                "localname":  "SaleOfTokensMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_SaleOfTokensRelatedPartyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale Of Tokens Related Party [Member]"
                            }
                        }
                    },
                "localname":  "SaleOfTokensRelatedPartyMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_SanctumAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sanctum Agreement [Member]"
                            }
                        }
                    },
                "localname":  "SanctumAgreementMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule Of Amount Owed On Prepayment Of Diagonal Lending Note [Table Text Block]",
                            "label":  "Schedule of Amount Owed on Prepayment of Diagonal Lending Note"
                            }
                        }
                    },
                "localname":  "ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "BOPO_SecuritiesPurchaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities Purchase Agreement [Member]",
                            "label":  "Securities Purchase Agreement [Member]"
                            }
                        }
                    },
                "localname":  "SecuritiesPurchaseAgreementMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_SeniorPromissoryNoteRelatedPartyDisclosureTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Senior Promissory Note \u2013 related party"
                            }
                        }
                    },
                "localname":  "SeniorPromissoryNoteRelatedPartyDisclosureTextBlock",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedParty"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "BOPO_SixCustomerMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Six Customer [Member]",
                            "label":  "Six Customer [Member]"
                            }
                        }
                    },
                "localname":  "SixCustomerMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_StockIssuedDuringPeriodShareCommonStockIssuedForAccruedSalaryRelatedParty":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period shares common stock issued for accrued salary related party.",
                            "label":  "Common stock issued for accrued salary - related party, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodShareCommonStockIssuedForAccruedSalaryRelatedParty",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "BOPO_StockIssuedDuringPeriodShareSaleOfCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period shares sale of common stock.",
                            "label":  "Sale of common stock, Shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodShareSaleOfCommonStock",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period shares conversion of convertible securities one.",
                            "label":  "Conversion of Series A preferred stock to notes payable - related party, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "BOPO_StockIssuedDuringPeriodValueCommonStockIssuedForAccruedSalaryRelatedParty":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period value common stock issued for accrued salary related party.",
                            "label":  "StockIssuedDuringPeriodValueCommonStockIssuedForAccruedSalaryRelatedParty",
                            "verboseLabel":  "Common stock issued for accrued salary - related party"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueCommonStockIssuedForAccruedSalaryRelatedParty",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period value conversion of convertible securities one.",
                            "label":  "Conversion of Series A preferred stock to notes payable - related party"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_StockIssuedDuringPeriodValueSaleOfCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period value sale of common stock.",
                            "label":  "Sale of common stock"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueSaleOfCommonStock",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_StockPurchaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock Purchase Agreement [Member]"
                            }
                        }
                    },
                "localname":  "StockPurchaseAgreementMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_TechnologyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Technology [Member]",
                            "label":  "Technology [Member]"
                            }
                        }
                    },
                "localname":  "TechnologyMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ThirdPartiesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Third Parties [Member]",
                            "label":  "Third Parties [Member]"
                            }
                        }
                    },
                "localname":  "ThirdPartiesMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ThirdPartyInvestorMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Third Party Investor [Member]",
                            "label":  "Third Party Investor [Member]"
                            }
                        }
                    },
                "localname":  "ThirdPartyInvestorMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ThirdPartyInvestorTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Third Party Investor Two [Member]",
                            "label":  "Third Party Investor Two [Member]"
                            }
                        }
                    },
                "localname":  "ThirdPartyInvestorTwoMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_ThreeNotesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Three Notes [Member]",
                            "label":  "Three Notes [Member]"
                            }
                        }
                    },
                "localname":  "ThreeNotesMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "BOPO_TokenPrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Token price.",
                            "label":  "Token price"
                            }
                        }
                    },
                "localname":  "TokenPrice",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "BOPO_TokensIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tokens issued during period shares new issues.",
                            "label":  "Tokens issued during period shares"
                            }
                        }
                    },
                "localname":  "TokensIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "BOPO_TokensIssuedDuringPeriodSharesNewIssuesValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tokens issued during period shares new issues value.",
                            "label":  "Tokens issued during period value new issues"
                            }
                        }
                    },
                "localname":  "TokensIssuedDuringPeriodSharesNewIssuesValue",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "BOPO_TroyMacDonaldMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Troy Mac Donald [Member]",
                            "label":  "Troy Mac Donald [Member]"
                            }
                        }
                    },
                "localname":  "TroyMacDonaldMember",
                "nsuri":  "http://biopowercorp.com/20220831",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_AmendmentDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of changes contained within amended document.",
                            "label":  "Amendment Description"
                            }
                        }
                    },
                "localname":  "AmendmentDescription",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AnnualInformationForm":  {
                "auth_ref":  [
                    "r473"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
                            "label":  "Annual Information Form"
                            }
                        }
                    },
                "localname":  "AnnualInformationForm",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AuditedAnnualFinancialStatements":  {
                "auth_ref":  [
                    "r473"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
                            "label":  "Audited Annual Financial Statements"
                            }
                        }
                    },
                "localname":  "AuditedAnnualFinancialStatements",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CountryRegion":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Region code of country",
                            "label":  "Country Region"
                            }
                        }
                    },
                "localname":  "CountryRegion",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentAccountingStandard":  {
                "auth_ref":  [
                    "r472"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S.  GAAP', 'International Financial Reporting Standards', or 'Other'.",
                            "label":  "Document Accounting Standard"
                            }
                        }
                    },
                "localname":  "DocumentAccountingStandard",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "accountingStandardItemType"
                },
            "dei_DocumentAnnualReport":  {
                "auth_ref":  [
                    "r470",
                    "r472",
                    "r473"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an annual report.",
                            "label":  "Document Annual Report"
                            }
                        }
                    },
                "localname":  "DocumentAnnualReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentPeriodStartDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The start date of the period covered in the document, in YYYY-MM-DD format.",
                            "label":  "Document Period Start Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodStartDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r471"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentRegistrationStatement":  {
                "auth_ref":  [
                    "r459"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a registration statement.",
                            "label":  "Document Registration Statement"
                            }
                        }
                    },
                "localname":  "DocumentRegistrationStatement",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentShellCompanyEventDate":  {
                "auth_ref":  [
                    "r472"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date of event requiring a shell company report.",
                            "label":  "Document Shell Company Event Date"
                            }
                        }
                    },
                "localname":  "DocumentShellCompanyEventDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentShellCompanyReport":  {
                "auth_ref":  [
                    "r472"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
                            "label":  "Document Shell Company Report"
                            }
                        }
                    },
                "localname":  "DocumentShellCompanyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r474"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_DocumentsIncorporatedByReferenceTextBlock":  {
                "auth_ref":  [
                    "r462"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Documents incorporated by reference.",
                            "label":  "Documents Incorporated by Reference [Text Block]"
                            }
                        }
                    },
                "localname":  "DocumentsIncorporatedByReferenceTextBlock",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine2":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 2 such as Street or Suite number",
                            "label":  "Entity Address, Address Line Two"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine2",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine3":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 3 such as an Office Park",
                            "label":  "Entity Address, Address Line Three"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine3",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCountry":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "ISO 3166-1 alpha-2 country code.",
                            "label":  "Entity Address, Country"
                            }
                        }
                    },
                "localname":  "EntityAddressCountry",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "countryCodeItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityBankruptcyProceedingsReportingCurrent":  {
                "auth_ref":  [
                    "r465"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
                            "label":  "Entity Bankruptcy Proceedings, Reporting Current"
                            }
                        }
                    },
                "localname":  "EntityBankruptcyProceedingsReportingCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "All the names of the entities being reported upon in a document.  Any legal structure used to conduct activities or to hold assets.  Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts.  This item does not include business and geographical segments which are included in the geographical or business segments domains."
                            }
                        }
                    },
                "localname":  "EntityDomain",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityExTransitionPeriod":  {
                "auth_ref":  [
                    "r485"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
                            "label":  "Elected Not To Use the Extended Transition Period"
                            }
                        }
                    },
                "localname":  "EntityExTransitionPeriod",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r482"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityPrimarySicNumber":  {
                "auth_ref":  [
                    "r473"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary Standard Industrial Classification (SIC) Number for the Entity.",
                            "label":  "Entity Primary SIC Number"
                            }
                        }
                    },
                "localname":  "EntityPrimarySicNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "sicNumberItemType"
                },
            "dei_EntityPublicFloat":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
                            "label":  "Entity Public Float"
                            }
                        }
                    },
                "localname":  "EntityPublicFloat",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_EntityVoluntaryFilers":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
                            "label":  "Entity Voluntary Filers"
                            }
                        }
                    },
                "localname":  "EntityVoluntaryFilers",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "auth_ref":  [
                    "r483"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
                            "label":  "Entity Well-known Seasoned Issuer"
                            }
                        }
                    },
                "localname":  "EntityWellKnownSeasonedIssuer",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_Extension":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Extension number for local phone number.",
                            "label":  "Extension"
                            }
                        }
                    },
                "localname":  "Extension",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_LegalEntityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The set of legal entities associated with a report.",
                            "label":  "Legal Entity [Axis]"
                            }
                        }
                    },
                "localname":  "LegalEntityAxis",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_NoTradingSymbolFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a security having no trading symbol.",
                            "label":  "No Trading Symbol Flag"
                            }
                        }
                    },
                "localname":  "NoTradingSymbolFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "trueItemType"
                },
            "dei_OtherReportingStandardItemNumber":  {
                "auth_ref":  [
                    "r472"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
                            "label":  "Other Reporting Standard Item Number"
                            }
                        }
                    },
                "localname":  "OtherReportingStandardItemNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "otherReportingStandardItemNumberItemType"
                },
            "dei_PreCommencementIssuerTenderOffer":  {
                "auth_ref":  [
                    "r466"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
                            "label":  "Pre-commencement Issuer Tender Offer"
                            }
                        }
                    },
                "localname":  "PreCommencementIssuerTenderOffer",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_PreCommencementTenderOffer":  {
                "auth_ref":  [
                    "r467"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
                            "label":  "Pre-commencement Tender Offer"
                            }
                        }
                    },
                "localname":  "PreCommencementTenderOffer",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r460"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_Security12gTitle":  {
                "auth_ref":  [
                    "r464"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(g) registered security.",
                            "label":  "Title of 12(g) Security"
                            }
                        }
                    },
                "localname":  "Security12gTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r463"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_SecurityReportingObligation":  {
                "auth_ref":  [
                    "r468"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
                            "label":  "Security Reporting Obligation"
                            }
                        }
                    },
                "localname":  "SecurityReportingObligation",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "securityReportingObligationItemType"
                },
            "dei_SolicitingMaterial":  {
                "auth_ref":  [
                    "r469"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
                            "label":  "Soliciting Material"
                            }
                        }
                    },
                "localname":  "SolicitingMaterial",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "dei_WrittenCommunications":  {
                "auth_ref":  [
                    "r484"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
                            "label":  "Written Communications"
                            }
                        }
                    },
                "localname":  "WrittenCommunications",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "srt_ChiefExecutiveOfficerMember":  {
                "auth_ref":  [
                    "r136"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Chief Executive Officer [Member]"
                            }
                        }
                    },
                "localname":  "ChiefExecutiveOfficerMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ChiefFinancialOfficerMember":  {
                "auth_ref":  [
                    "r136"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Chief Financial Officer [Member]"
                            }
                        }
                    },
                "localname":  "ChiefFinancialOfficerMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ChiefOperatingOfficerMember":  {
                "auth_ref":  [
                    "r136",
                    "r367"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Chief Operating Officer [Member]"
                            }
                        }
                    },
                "localname":  "ChiefOperatingOfficerMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_EquityMethodInvesteeNameDomain":  {
                "auth_ref":  [
                    ],
                "localname":  "EquityMethodInvesteeNameDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MajorCustomersAxis":  {
                "auth_ref":  [
                    "r135",
                    "r269",
                    "r271",
                    "r447"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Axis]"
                            }
                        }
                    },
                "localname":  "MajorCustomersAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r177",
                    "r178",
                    "r179",
                    "r180",
                    "r198",
                    "r237",
                    "r276",
                    "r278",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r406",
                    "r445",
                    "r448",
                    "r457",
                    "r458"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r177",
                    "r178",
                    "r179",
                    "r180",
                    "r198",
                    "r237",
                    "r276",
                    "r278",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r406",
                    "r445",
                    "r448",
                    "r457",
                    "r458"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_NameOfMajorCustomerDomain":  {
                "auth_ref":  [
                    "r135",
                    "r269",
                    "r271",
                    "r447"
                    ],
                "localname":  "NameOfMajorCustomerDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ProductOrServiceAxis":  {
                "auth_ref":  [
                    "r133",
                    "r178",
                    "r179",
                    "r269",
                    "r270",
                    "r408",
                    "r444",
                    "r446"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Axis]"
                            }
                        }
                    },
                "localname":  "ProductOrServiceAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ProductsAndServicesDomain":  {
                "auth_ref":  [
                    "r133",
                    "r178",
                    "r179",
                    "r269",
                    "r270",
                    "r408",
                    "r444",
                    "r446"
                    ],
                "localname":  "ProductsAndServicesDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r172",
                    "r177",
                    "r178",
                    "r179",
                    "r180",
                    "r198",
                    "r237",
                    "r273",
                    "r276",
                    "r278",
                    "r307",
                    "r308",
                    "r309",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r406",
                    "r445",
                    "r448",
                    "r457",
                    "r458"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r172",
                    "r177",
                    "r178",
                    "r179",
                    "r180",
                    "r198",
                    "r237",
                    "r273",
                    "r276",
                    "r278",
                    "r307",
                    "r308",
                    "r309",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r406",
                    "r445",
                    "r448",
                    "r457",
                    "r458"
                    ],
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":  {
                "auth_ref":  [
                    "r151"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investment, Name [Axis]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualAxis":  {
                "auth_ref":  [
                    "r136",
                    "r367"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Axis]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "auth_ref":  [
                    ],
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r28"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
                            "label":  "Accounts payable and accrued expenses"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsPayableRelatedPartiesCurrent":  {
                "auth_ref":  [
                    "r26",
                    "r77",
                    "r366",
                    "r368"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount for accounts payable to related parties.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts payable and accrued expenses - related party"
                            }
                        }
                    },
                "localname":  "AccountsPayableRelatedPartiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "auth_ref":  [
                    "r137",
                    "r138"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
                            "label":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedSalariesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r425",
                    "r440"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.",
                            "label":  "Accrued salary"
                            }
                        }
                    },
                "localname":  "AccruedSalariesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r17",
                    "r373"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder.  Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
                            "label":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r80",
                    "r81",
                    "r82",
                    "r312",
                    "r313",
                    "r314",
                    "r343"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to reconcile net loss to net"
                            }
                        }
                    },
                "localname":  "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of other increase (decrease) in additional paid in capital (APIC).",
                            "label":  "Adjustments to Additional Paid in Capital, Other",
                            "verboseLabel":  "Derivative liability"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to reconcile net loss to net cash used in operating activities"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "auth_ref":  [
                    "r311"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized.",
                            "label":  "Accrued compensation"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfDebtDiscountPremium":  {
                "auth_ref":  [
                    "r47",
                    "r59",
                    "r218",
                    "r357"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments.  Excludes amortization of financing costs.  Alternate captions include noncash interest expense.",
                            "label":  "Amortization of debt discount"
                            }
                        }
                    },
                "localname":  "AmortizationOfDebtDiscountPremium",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ArrangementsAndNonarrangementTransactionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
                            }
                        }
                    },
                "localname":  "ArrangementsAndNonarrangementTransactionsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r9",
                    "r76",
                    "r123",
                    "r126",
                    "r131",
                    "r152",
                    "r183",
                    "r184",
                    "r185",
                    "r186",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r334",
                    "r337",
                    "r349",
                    "r371",
                    "r373",
                    "r421",
                    "r434"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets [Default Label]",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r282",
                    "r283",
                    "r284",
                    "r286",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r302",
                    "r303",
                    "r306",
                    "r307",
                    "r308",
                    "r309",
                    "r310"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BasisOfAccountingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Basis of Presentation"
                            }
                        }
                    },
                "localname":  "BasisOfAccountingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessAcquisitionAcquireeDomain":  {
                "auth_ref":  [
                    "r275",
                    "r277",
                    "r329"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAcquireeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_BusinessAcquisitionAxis":  {
                "auth_ref":  [
                    "r275",
                    "r277",
                    "r327",
                    "r328",
                    "r329"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by business combination or series of individually immaterial business combinations.",
                            "label":  "Business Acquisition [Axis]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity":  {
                "auth_ref":  [
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.",
                            "label":  "Business combination description"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionDescriptionOfAcquiredEntity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessCombinationConsiderationTransferred1":  {
                "auth_ref":  [
                    "r330",
                    "r331",
                    "r332"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
                            "label":  "Cash consideration, acquisition"
                            }
                        }
                    },
                "localname":  "BusinessCombinationConsiderationTransferred1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAcquiredFromAcquisition":  {
                "auth_ref":  [
                    "r49"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
                            "label":  "Proceeds from acquisition"
                            }
                        }
                    },
                "localname":  "CashAcquiredFromAcquisition",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r3",
                    "r8",
                    "r61"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and cash equivlants",
                            "verboseLabel":  "Cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "auth_ref":  [
                    "r62"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
                            "label":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":  {
                "auth_ref":  [
                    "r55",
                    "r61",
                    "r67"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
                            "periodEndLabel":  "Cash and cash equivalents at end of period",
                            "periodStartLabel":  "Cash and cash equivalents at beginning of period"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r55",
                    "r350"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Net increase in cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r15",
                    "r73",
                    "r76",
                    "r94",
                    "r95",
                    "r96",
                    "r98",
                    "r100",
                    "r107",
                    "r108",
                    "r109",
                    "r152",
                    "r183",
                    "r187",
                    "r188",
                    "r189",
                    "r192",
                    "r193",
                    "r235",
                    "r236",
                    "r240",
                    "r244",
                    "r251",
                    "r349",
                    "r475"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r34",
                    "r426",
                    "r439"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and Contingencies (Note 9)"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r173",
                    "r174",
                    "r175",
                    "r181",
                    "r456"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r80",
                    "r81",
                    "r343"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r15"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common stock, par value"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r15"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common stock, shares authorized"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r15"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common stock, shares issued",
                            "verboseLabel":  "Common Stock, Shares, Issued"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r15",
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common stock, shares outstanding",
                            "verboseLabel":  "Common Stock, Shares, Outstanding"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r15",
                    "r373"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common stock, $.0001 par value: 500,000,000 authorized; 45,625,000 and 45,000,000 issued and outstanding on August 31, 2022 and November 30, 2021, respectively"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConcentrationRiskBenchmarkDomain":  {
                "auth_ref":  [
                    "r116",
                    "r117",
                    "r135",
                    "r347",
                    "r348",
                    "r455"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The denominator in a calculation of a disclosed concentration risk percentage."
                            }
                        }
                    },
                "localname":  "ConcentrationRiskBenchmarkDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskByBenchmarkAxis":  {
                "auth_ref":  [
                    "r116",
                    "r117",
                    "r135",
                    "r347",
                    "r348",
                    "r454",
                    "r455"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by benchmark of concentration risk.",
                            "label":  "Concentration Risk Benchmark [Axis]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskByBenchmarkAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskByTypeAxis":  {
                "auth_ref":  [
                    "r116",
                    "r117",
                    "r135",
                    "r347",
                    "r348",
                    "r454",
                    "r455"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
                            "label":  "Concentration Risk Type [Axis]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskCreditRisk":  {
                "auth_ref":  [
                    "r112",
                    "r431"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for credit risk.",
                            "label":  "Concentration"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskCreditRisk",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConcentrationRiskPercentage1":  {
                "auth_ref":  [
                    "r116",
                    "r117",
                    "r135",
                    "r347",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
                            "label":  "Concentration risk, percentage"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskPercentage1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ConcentrationRiskTypeDomain":  {
                "auth_ref":  [
                    "r116",
                    "r117",
                    "r135",
                    "r347",
                    "r348",
                    "r455"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
                            }
                        }
                    },
                "localname":  "ConcentrationRiskTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConsolidationPolicyTextBlock":  {
                "auth_ref":  [
                    "r69",
                    "r336"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
                            "label":  "Principles of Consolidation"
                            }
                        }
                    },
                "localname":  "ConsolidationPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConversionOfStockDescription":  {
                "auth_ref":  [
                    "r64",
                    "r65",
                    "r66"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique description of a noncash or part noncash stock conversion.  The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Conversion of stock, description"
                            }
                        }
                    },
                "localname":  "ConversionOfStockDescription",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConversionOfStockSharesConverted1":  {
                "auth_ref":  [
                    "r64",
                    "r65",
                    "r66"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares converted in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Stock conversion, shares"
                            }
                        }
                    },
                "localname":  "ConversionOfStockSharesConverted1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ConversionOfStockSharesIssued1":  {
                "auth_ref":  [
                    "r64",
                    "r65",
                    "r66"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Stock conversion, issued shares",
                            "verboseLabel":  "Conversion of stock shares issued"
                            }
                        }
                    },
                "localname":  "ConversionOfStockSharesIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ConvertibleDebt":  {
                "auth_ref":  [
                    "r12",
                    "r423",
                    "r435"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
                            "label":  "Convertible Debt",
                            "verboseLabel":  "Convertible debt"
                            }
                        }
                    },
                "localname":  "ConvertibleDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleDebtCurrent":  {
                "auth_ref":  [
                    "r10"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer.  Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
                            "label":  "Convertible debt"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleDebtMember":  {
                "auth_ref":  [
                    "r194",
                    "r195",
                    "r196",
                    "r198",
                    "r208",
                    "r209",
                    "r210",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r226",
                    "r227",
                    "r228",
                    "r229"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
                            "label":  "Convertible Debt [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CustomerConcentrationRiskMember":  {
                "auth_ref":  [
                    "r115",
                    "r135"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues.  The risk is the materially adverse effects of loss of a significant customer.",
                            "label":  "Customer Concentration Risk [Member]"
                            }
                        }
                    },
                "localname":  "CustomerConcentrationRiskMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DebtDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtDisclosureTextBlock":  {
                "auth_ref":  [
                    "r72",
                    "r201",
                    "r202",
                    "r203",
                    "r204",
                    "r205",
                    "r206",
                    "r207",
                    "r212",
                    "r219",
                    "r220",
                    "r222",
                    "r230"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
                            "label":  "Notes Payable and Convertible Debt"
                            }
                        }
                    },
                "localname":  "DebtDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebt"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DebtInstrumentAnnualPrincipalPayment":  {
                "auth_ref":  [
                    "r12"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the total principal payments made during the annual reporting period.",
                            "label":  "Debt payment amount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAnnualPrincipalPayment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentAxis":  {
                "auth_ref":  [
                    "r10",
                    "r11",
                    "r12",
                    "r75",
                    "r78",
                    "r195",
                    "r196",
                    "r197",
                    "r198",
                    "r199",
                    "r200",
                    "r202",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r359",
                    "r422",
                    "r423",
                    "r433"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
                            "label":  "Debt Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentConvertibleConversionPrice1":  {
                "auth_ref":  [
                    "r197",
                    "r223"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The price per share of the conversion feature embedded in the debt instrument.",
                            "label":  "Conversion price per share",
                            "verboseLabel":  "Debt instrument, price per share"
                            }
                        }
                    },
                "localname":  "DebtInstrumentConvertibleConversionPrice1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
                            "label":  "Debt instrument, conversion rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentDescription":  {
                "auth_ref":  [
                    "r10",
                    "r12",
                    "r252",
                    "r422",
                    "r423",
                    "r430",
                    "r433"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment.  This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions.  The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.",
                            "label":  "Debt instrument, description"
                            }
                        }
                    },
                "localname":  "DebtInstrumentDescription",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentFaceAmount":  {
                "auth_ref":  [
                    "r195",
                    "r226",
                    "r227",
                    "r358",
                    "r359",
                    "r360"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face (par) amount of debt instrument at time of issuance.",
                            "label":  "Debt instrument, principal amount",
                            "terseLabel":  "Principal amount",
                            "verboseLabel":  "Debt instruments, principal amount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentFaceAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentInterestRateDuringPeriod":  {
                "auth_ref":  [
                    "r31",
                    "r215",
                    "r358"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average effective interest rate during the reporting period.",
                            "label":  "Debt instrument, interest rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateDuringPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentInterestRateEffectivePercentage":  {
                "auth_ref":  [
                    "r31",
                    "r224",
                    "r358",
                    "r359"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
                            "label":  "Debt instrument, original percentage",
                            "terseLabel":  "Debt instrument, interest rate",
                            "verboseLabel":  "Debt instrument, interest rate, effective percentage"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateEffectivePercentage",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentInterestRateStatedPercentage":  {
                "auth_ref":  [
                    "r31",
                    "r196"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contractual interest rate for funds borrowed, under the debt agreement.",
                            "label":  "Interest rate",
                            "terseLabel":  "Debt instrument, interest rate",
                            "verboseLabel":  "Debt instrument, interest"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateStatedPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentMaturityDate":  {
                "auth_ref":  [
                    "r32",
                    "r198",
                    "r346"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
                            "label":  "Debt instrument maturity date",
                            "verboseLabel":  "Debt instrumnet, maturity date"
                            }
                        }
                    },
                "localname":  "DebtInstrumentMaturityDate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "dateItemType"
                },
            "us-gaap_DebtInstrumentMaturityDateDescription":  {
                "auth_ref":  [
                    "r32"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
                            "label":  "Maturity date"
                            }
                        }
                    },
                "localname":  "DebtInstrumentMaturityDateDescription",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentNameDomain":  {
                "auth_ref":  [
                    "r33",
                    "r75",
                    "r78",
                    "r195",
                    "r196",
                    "r197",
                    "r198",
                    "r199",
                    "r200",
                    "r202",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r359"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
                            }
                        }
                    },
                "localname":  "DebtInstrumentNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtInstrumentUnamortizedDiscountCurrent":  {
                "auth_ref":  [
                    "r357",
                    "r360"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
                            "label":  "Convertible debt, discount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentUnamortizedDiscountCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredRevenueCurrent":  {
                "auth_ref":  [
                    "r11"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
                            "label":  "Deferred revenue"
                            }
                        }
                    },
                "localname":  "DeferredRevenueCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeGainOnDerivative":  {
                "auth_ref":  [
                    "r340"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        },
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OtherNonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase in the fair value of derivatives recognized in the income statement.",
                            "label":  "Gsin on derivative",
                            "negatedLabel":  "Gain on derivative"
                            }
                        }
                    },
                "localname":  "DerivativeGainOnDerivative",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows",
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r37"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer.  Includes assets not subject to a master netting arrangement and not elected to be offset.",
                            "label":  "Derivative liability"
                            }
                        }
                    },
                "localname":  "DerivativeLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EarningsPerShareBasic":  {
                "auth_ref":  [
                    "r45",
                    "r85",
                    "r86",
                    "r87",
                    "r88",
                    "r89",
                    "r93",
                    "r94",
                    "r98",
                    "r99",
                    "r100",
                    "r103",
                    "r104",
                    "r344",
                    "r345",
                    "r428",
                    "r443"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
                            "label":  "Net loss per common share: basic and diluted"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "auth_ref":  [
                    "r101",
                    "r102"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
                            "label":  "Net Loss per Share"
                            }
                        }
                    },
                "localname":  "EarningsPerSharePolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r0",
                    "r41",
                    "r42",
                    "r43",
                    "r80",
                    "r81",
                    "r82",
                    "r84",
                    "r90",
                    "r92",
                    "r106",
                    "r153",
                    "r251",
                    "r258",
                    "r312",
                    "r313",
                    "r314",
                    "r324",
                    "r325",
                    "r343",
                    "r351",
                    "r352",
                    "r353",
                    "r354",
                    "r355",
                    "r356",
                    "r361",
                    "r449",
                    "r450",
                    "r451"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityMethodInvestmentOwnershipPercentage":  {
                "auth_ref":  [
                    "r151"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
                            "label":  "Ownership, percentage"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestmentOwnershipPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_FinancialInstrumentAxis":  {
                "auth_ref":  [
                    "r146",
                    "r147",
                    "r148",
                    "r149",
                    "r150",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r159",
                    "r160",
                    "r161",
                    "r162",
                    "r221",
                    "r249",
                    "r341",
                    "r376",
                    "r377",
                    "r378",
                    "r379",
                    "r380",
                    "r381",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r388",
                    "r389",
                    "r390",
                    "r391",
                    "r392",
                    "r393",
                    "r394",
                    "r395",
                    "r396",
                    "r397",
                    "r398",
                    "r399",
                    "r400",
                    "r401",
                    "r402",
                    "r403",
                    "r404",
                    "r405",
                    "r475",
                    "r476",
                    "r477",
                    "r478",
                    "r479",
                    "r480",
                    "r481"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of financial instrument.",
                            "label":  "Financial Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "FinancialInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r40",
                    "r318",
                    "r319",
                    "r320",
                    "r321",
                    "r322",
                    "r323"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxesPaidNet":  {
                "auth_ref":  [
                    "r63"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
                            "label":  "Cash paid for income taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":  {
                "auth_ref":  [
                    "r58"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
                            "label":  "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
                            "verboseLabel":  "Accounts payable and accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties":  {
                "auth_ref":  [
                    "r58"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
                            "label":  "Increase (Decrease) in Accounts Payable, Related Parties",
                            "verboseLabel":  "Accounts payable and accrued expenses - related party"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayableRelatedParties",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "auth_ref":  [
                    "r58"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedLabel":  "Increase in accounts receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedSalaries":  {
                "auth_ref":  [
                    "r58"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the period in accrued salaries.",
                            "label":  "Decrease in accrued salaries"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedSalaries",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInDeferredRevenue":  {
                "auth_ref":  [
                    "r58"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
                            "label":  "Deferred revenge"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInDeferredRevenue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInInventories":  {
                "auth_ref":  [
                    "r58"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
                            "label":  "Increase (Decrease) in Inventories",
                            "negatedLabel":  "increase in inventory"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInInventories",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Changes in operating assets and liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidExpense":  {
                "auth_ref":  [
                    "r58"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
                            "label":  "Increase (Decrease) in Prepaid Expense",
                            "negatedLabel":  "Increase in prepaid expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r168",
                    "r169"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-Lived Intangible Assets [Axis]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r168",
                    "r169"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill.  A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IndefiniteLivedLicenseAgreements":  {
                "auth_ref":  [
                    "r169"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit.",
                            "label":  "Exclusive license amount"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedLicenseAgreements",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseDebt":  {
                "auth_ref":  [
                    "r47",
                    "r216",
                    "r225",
                    "r228",
                    "r229"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
                            "label":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpenseDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseOther":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OtherNonoperatingIncomeExpense",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest expense classified as other.",
                            "label":  "Interest Expense, Other",
                            "negatedLabel":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpenseOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseRelatedParty":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OtherNonoperatingIncomeExpense",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest expense incurred on a debt or other obligation to related party.",
                            "label":  "Interest expense related party",
                            "negatedLabel":  "Interest expense -related party"
                            }
                        }
                    },
                "localname":  "InterestExpenseRelatedParty",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPaidNet":  {
                "auth_ref":  [
                    "r54",
                    "r56",
                    "r63"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity.  Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
                            "label":  "Cash paid for interest"
                            }
                        }
                    },
                "localname":  "InterestPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPayableCurrent":  {
                "auth_ref":  [
                    "r29"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Interest Payable, Current",
                            "verboseLabel":  "Accrued interest"
                            }
                        }
                    },
                "localname":  "InterestPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPayableCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r425",
                    "r440"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest payable on debt, including, but not limited to, trade payables.",
                            "label":  "Accrued interest"
                            }
                        }
                    },
                "localname":  "InterestPayableCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestReceivable":  {
                "auth_ref":  [
                    "r16"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount as of the balance sheet date of interest earned but not received.  Also called accrued interest or accrued interest receivable.",
                            "label":  "Accurued interest"
                            }
                        }
                    },
                "localname":  "InterestReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryNet":  {
                "auth_ref":  [
                    "r4",
                    "r23",
                    "r373"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
                            "label":  "Inventory"
                            }
                        }
                    },
                "localname":  "InventoryNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryPolicyTextBlock":  {
                "auth_ref":  [
                    "r7",
                    "r22",
                    "r70",
                    "r105",
                    "r163",
                    "r164",
                    "r165",
                    "r407"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
                            "label":  "Inventory, Policy [Policy Text Block]",
                            "verboseLabel":  "Inventory"
                            }
                        }
                    },
                "localname":  "InventoryPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InvestorMember":  {
                "auth_ref":  [
                    "r364",
                    "r365"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
                            "label":  "Investor [Member]"
                            }
                        }
                    },
                "localname":  "InvestorMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims":  {
                "auth_ref":  [
                    "r59"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
                            "label":  "Common stock issued for services"
                            }
                        }
                    },
                "localname":  "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r21",
                    "r76",
                    "r152",
                    "r349",
                    "r373",
                    "r424",
                    "r437"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total liabilities and stockholders\u2019 deficit"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Stockholders\u2019 Deficit"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r6",
                    "r30",
                    "r76",
                    "r152",
                    "r183",
                    "r184",
                    "r185",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r335",
                    "r337",
                    "r338",
                    "r349",
                    "r371",
                    "r372",
                    "r373"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LoansPayable":  {
                "auth_ref":  [
                    "r12",
                    "r423",
                    "r432"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
                            "label":  "Loans payable"
                            }
                        }
                    },
                "localname":  "LoansPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongtermDebtTypeAxis":  {
                "auth_ref":  [
                    "r33"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-term debt.",
                            "label":  "Long-Term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongtermDebtTypeDomain":  {
                "auth_ref":  [
                    "r33",
                    "r182"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r55"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash flow from financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r55",
                    "r57",
                    "r60"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash used in operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash flows from operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r1",
                    "r38",
                    "r39",
                    "r43",
                    "r44",
                    "r60",
                    "r76",
                    "r83",
                    "r85",
                    "r86",
                    "r87",
                    "r88",
                    "r91",
                    "r92",
                    "r97",
                    "r123",
                    "r125",
                    "r127",
                    "r130",
                    "r132",
                    "r152",
                    "r183",
                    "r184",
                    "r185",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r345",
                    "r349",
                    "r427",
                    "r442"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net loss",
                            "totalLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "Recent Accounting Pronouncements"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NoncashInvestingAndFinancingItemsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Supplemental disclosure of cash flow information:"
                            }
                        }
                    },
                "localname":  "NoncashInvestingAndFinancingItemsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NotesPayable":  {
                "auth_ref":  [
                    "r12",
                    "r423",
                    "r435"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
                            "label":  "Balance",
                            "verboseLabel":  "Notes Payable"
                            }
                        }
                    },
                "localname":  "NotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NotesPayableCurrent":  {
                "auth_ref":  [
                    "r28"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
                            "label":  "Notes payable"
                            }
                        }
                    },
                "localname":  "NotesPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent":  {
                "auth_ref":  [
                    "r25",
                    "r77",
                    "r366"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount for notes payable (written promise to pay), due to related parties.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Notes payable - related parties"
                            }
                        }
                    },
                "localname":  "NotesPayableRelatedPartiesClassifiedCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r77",
                    "r365",
                    "r441"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount for notes payable (written promise to pay), due to related parties.",
                            "label":  "Notes payable to related parties"
                            }
                        }
                    },
                "localname":  "NotesPayableRelatedPartiesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services.  Includes selling, general and administrative expense.",
                            "label":  "Operating Expenses",
                            "totalLabel":  "Total operating expenses"
                            }
                        }
                    },
                "localname":  "OperatingExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating expenses"
                            }
                        }
                    },
                "localname":  "OperatingExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r123",
                    "r125",
                    "r127",
                    "r130",
                    "r132"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Income / (Loss) from operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r2",
                    "r339"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
                            "label":  "Organization"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/Organization"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r48"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other Nonoperating Income (Expense)",
                            "totalLabel":  "Total other expenses"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other expenses"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherNotesPayable":  {
                "auth_ref":  [
                    "r12",
                    "r423",
                    "r435"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term notes payable classified as other.",
                            "label":  "Other Notes Payable",
                            "verboseLabel":  "Notes payable"
                            }
                        }
                    },
                "localname":  "OtherNotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireIntangibleAssets":  {
                "auth_ref":  [
                    "r50"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
                            "label":  "Payment of exchange"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireIntangibleAssets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation.  Preferred shares typically represent an ownership interest in the company.",
                            "label":  "Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "PreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r14",
                    "r235"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred stock, par value"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r14"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred stock, shares authorized"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r14",
                    "r235"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred stock, shares issued",
                            "verboseLabel":  "Preferred Stock, Shares Issued"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r14"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred stock, shares outstanding",
                            "verboseLabel":  "Preferred Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r14",
                    "r373"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred stock, value"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PreferredStockVotingRights":  {
                "auth_ref":  [
                    "r14",
                    "r252"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of voting rights of nonredeemable preferred stock.  Includes eligibility to vote and votes per share owned.  Include also, if any, unusual voting rights.",
                            "label":  "Number of preferred stock voting rights"
                            }
                        }
                    },
                "localname":  "PreferredStockVotingRights",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PrepaidExpenseCurrent":  {
                "auth_ref":  [
                    "r5",
                    "r24",
                    "r166",
                    "r167"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid expemses"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromConvertibleDebt":  {
                "auth_ref":  [
                    "r52"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
                            "label":  "Convertible notes payable"
                            }
                        }
                    },
                "localname":  "ProceedsFromConvertibleDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r51"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds from issuance of common stock"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProductInformationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Product Information [Line Items]"
                            }
                        }
                    },
                "localname":  "ProductInformationLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ProductLiabilityContingencyLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Product Liability Contingency [Line Items]"
                            }
                        }
                    },
                "localname":  "ProductLiabilityContingencyLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ProductLiabilityContingencyTable":  {
                "auth_ref":  [
                    "r176",
                    "r177",
                    "r178",
                    "r179"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.",
                            "label":  "Product Liability Contingency [Table]"
                            }
                        }
                    },
                "localname":  "ProductLiabilityContingencyTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r171"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Long-Lived Tangible Asset [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r171",
                    "r373",
                    "r429",
                    "r438"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Value of purchased assets"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r170"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyDomain":  {
                "auth_ref":  [
                    "r274",
                    "r364",
                    "r365"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
                            }
                        }
                    },
                "localname":  "RelatedPartyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Related Party Transaction [Line Items]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionRate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
                            "label":  "Related party transaction, rate"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "auth_ref":  [
                    "r274",
                    "r364",
                    "r368",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r414",
                    "r415",
                    "r416",
                    "r417",
                    "r418",
                    "r419",
                    "r420"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r362",
                    "r363",
                    "r365",
                    "r369",
                    "r370"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentsOfLongTermDebt":  {
                "auth_ref":  [
                    "r53"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
                            "label":  "Repayments of Long-Term Debt",
                            "negatedLabel":  "Repayment of Notes payable Senior secured - related party"
                            }
                        }
                    },
                "localname":  "RepaymentsOfLongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r18",
                    "r258",
                    "r373",
                    "r436",
                    "r452",
                    "r453"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Accumulated deficit",
                            "negatedLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r0",
                    "r80",
                    "r81",
                    "r82",
                    "r84",
                    "r90",
                    "r92",
                    "r153",
                    "r312",
                    "r313",
                    "r314",
                    "r324",
                    "r325",
                    "r343",
                    "r449",
                    "r451"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "auth_ref":  [
                    "r121",
                    "r122",
                    "r124",
                    "r128",
                    "r129",
                    "r133",
                    "r134",
                    "r135",
                    "r268",
                    "r269",
                    "r408"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
                            "label":  "Total Revenue"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock":  {
                "auth_ref":  [
                    "r71",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r266",
                    "r267",
                    "r272"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for revenue from contract with customer.",
                            "label":  "Revenue Recognition"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevenuesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue:"
                            }
                        }
                    },
                "localname":  "RevenuesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SaleOfStockConsiderationReceivedOnTransaction":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash received on stock transaction after deduction of issuance costs.",
                            "label":  "Purchase price"
                            }
                        }
                    },
                "localname":  "SaleOfStockConsiderationReceivedOnTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
                            "label":  "Sale of Stock, Number of Shares Issued in Transaction",
                            "verboseLabel":  "Number of shares issued"
                            }
                        }
                    },
                "localname":  "SaleOfStockNumberOfSharesIssuedInTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SalesRevenueNetMember":  {
                "auth_ref":  [
                    "r116",
                    "r135"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
                            "label":  "Revenue Benchmark [Member]"
                            }
                        }
                    },
                "localname":  "SalesRevenueNetMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable":  {
                "auth_ref":  [
                    "r333"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfDebtTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
                            "label":  "Schedule of Notes Payable"
                            }
                        }
                    },
                "localname":  "ScheduleOfDebtTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfProductInformationTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing quantitative information concerning products or product lines by product or product line.",
                            "label":  "Schedule of Product Information [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfProductInformationTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable":  {
                "auth_ref":  [
                    "r366",
                    "r368"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of quantitative and qualitative information pertaining to related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Schedule of Related Party Transactions, by Related Party [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "auth_ref":  [
                    "r280",
                    "r281",
                    "r282",
                    "r283",
                    "r284",
                    "r286",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r302",
                    "r303",
                    "r306",
                    "r307",
                    "r308",
                    "r309",
                    "r310"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about share-based payment arrangement.",
                            "label":  "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShortTermDebtTable":  {
                "auth_ref":  [
                    "r27"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance.  It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
                            "label":  "Schedule of Short-Term Debt [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShortTermDebtTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r15",
                    "r73",
                    "r107",
                    "r108",
                    "r231",
                    "r232",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r244",
                    "r249",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255",
                    "r256",
                    "r257",
                    "r258"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r46"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
                            "label":  "Selling, general and administrative expenses"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SeriesAPreferredStockMember":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Series A preferred stock.",
                            "label":  "Series A Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "SeriesAPreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SeriesCPreferredStockMember":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Series C preferred stock.",
                            "label":  "Series C Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "SeriesCPreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r290"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net number of share options (or share units) granted during the period.",
                            "label":  "Number of shares issued"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
                            "label":  "Outstanding shares, percentage"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r282",
                    "r283",
                    "r284",
                    "r286",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r302",
                    "r303",
                    "r306",
                    "r307",
                    "r308",
                    "r309",
                    "r310"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement."
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "auth_ref":  [
                    "r285",
                    "r304",
                    "r305",
                    "r306",
                    "r307",
                    "r310",
                    "r315",
                    "r317"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost.",
                            "label":  "Stock-based Compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SharePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Price of a single share of a number of saleable stocks of a company.",
                            "label":  "Share price"
                            }
                        }
                    },
                "localname":  "SharePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharesIssuedPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share or per unit amount of equity securities issued.",
                            "label":  "Share issued price per share",
                            "verboseLabel":  "Issue price per share"
                            }
                        }
                    },
                "localname":  "SharesIssuedPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Ending balance, shares",
                            "periodStartLabel":  "Beginning balance, shares"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShortTermDebtLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Short-Term Debt [Line Items]"
                            }
                        }
                    },
                "localname":  "ShortTermDebtLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShortTermDebtTypeAxis":  {
                "auth_ref":  [
                    "r27"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of short-term debt arrangement.",
                            "label":  "Short-Term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "ShortTermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShortTermDebtTypeDomain":  {
                "auth_ref":  [
                    "r26"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
                            }
                        }
                    },
                "localname":  "ShortTermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r68",
                    "r79"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Summary of Significant Accounting Policies"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r15",
                    "r73",
                    "r76",
                    "r94",
                    "r95",
                    "r96",
                    "r98",
                    "r100",
                    "r107",
                    "r108",
                    "r109",
                    "r152",
                    "r183",
                    "r187",
                    "r188",
                    "r189",
                    "r192",
                    "r193",
                    "r235",
                    "r236",
                    "r240",
                    "r244",
                    "r251",
                    "r349",
                    "r475"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r0",
                    "r36",
                    "r41",
                    "r42",
                    "r43",
                    "r80",
                    "r81",
                    "r82",
                    "r84",
                    "r90",
                    "r92",
                    "r106",
                    "r153",
                    "r251",
                    "r258",
                    "r312",
                    "r313",
                    "r314",
                    "r324",
                    "r325",
                    "r343",
                    "r351",
                    "r352",
                    "r353",
                    "r354",
                    "r355",
                    "r356",
                    "r361",
                    "r449",
                    "r450",
                    "r451"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r80",
                    "r81",
                    "r82",
                    "r106",
                    "r408"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/BalanceSheetsParenthetical",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation":  {
                "auth_ref":  [
                    "r279",
                    "r316"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value, after forfeiture, of shares granted under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture",
                            "verboseLabel":  "Value of shares issued"
                            }
                        }
                    },
                "localname":  "StockGrantedDuringPeriodValueSharebasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssued1":  {
                "auth_ref":  [
                    "r64",
                    "r65",
                    "r66"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The fair value of stock issued in noncash financing activities.",
                            "label":  "Stock issued",
                            "negatedLabel":  "Conversion of Series A preferred stock to notes payable - related party"
                            }
                        }
                    },
                "localname":  "StockIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesAcquisitions":  {
                "auth_ref":  [
                    "r14",
                    "r15",
                    "r258"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued during the period pursuant to acquisitions.",
                            "label":  "Number of consideration shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesAcquisitions",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r35",
                    "r213",
                    "r251",
                    "r252",
                    "r258"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period as a result of the conversion of convertible securities.",
                            "label":  "Conversion of preferred stock to notes payable - related party, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued in lieu of cash for services contributed to the entity.  Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
                            "label":  "Common stock issued for services, shares",
                            "verboseLabel":  "Number of shares issued"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesIssuedForServices",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r14",
                    "r15",
                    "r251",
                    "r258"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Sales of preferred stock, shares",
                            "terseLabel":  "Shares issued, shares",
                            "verboseLabel":  "Shares of restriced common stock"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesOther":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued attributable to transactions classified as other.",
                            "label":  "Common stock issued for accrued severance, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures":  {
                "auth_ref":  [
                    "r14",
                    "r15",
                    "r251",
                    "r258"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
                            "label":  "Number of restricted stock, issued"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r36",
                    "r251",
                    "r258"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The gross value of stock issued during the period upon the conversion of convertible securities.",
                            "label":  "Conversion of preferred stock to notes payable - related party"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueIssuedForServices":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued in lieu of cash for services contributed to the entity.  Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
                            "label":  "Value of shares issued",
                            "verboseLabel":  "Common stock issued for services"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueIssuedForServices",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r14",
                    "r15",
                    "r251",
                    "r258"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Sales of preferred stock",
                            "verboseLabel":  "Value of shares issued"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueOther":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of shares of stock issued attributable to transactions classified as other.",
                            "label":  "Stock Issued During Period, Value, Other",
                            "verboseLabel":  "Common stock issued for accrued severance"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures":  {
                "auth_ref":  [
                    "r251",
                    "r258"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
                            "label":  "Value of restricted stock, issued"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r15",
                    "r19",
                    "r20",
                    "r76",
                    "r144",
                    "r152",
                    "r349",
                    "r373"
                    ],
                "calculation":  {
                    "http://biopowercorp.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "negatedLabel":  "Stockholders' deficit",
                            "periodEndLabel":  "Ending balance, value",
                            "periodStartLabel":  "Beginning balance, value",
                            "totalLabel":  "Total stockholders\u2019 deficit"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets",
                    "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit",
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders\u2019 deficit"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r74",
                    "r236",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243",
                    "r244",
                    "r245",
                    "r246",
                    "r247",
                    "r248",
                    "r250",
                    "r258",
                    "r259",
                    "r342"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders' Equity Note Disclosure [Text Block]",
                            "verboseLabel":  "Stockholders\u2019 deficit"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StockholdersDeficit"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StockholdersEquityPolicyTextBlock":  {
                "auth_ref":  [
                    "r233"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
                            "label":  "Stockholders\u2019 Equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "auth_ref":  [
                    "r374",
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
                            "label":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SubsequentEvents"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SupplementalCashFlowElementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental disclosure of cash flow information:"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowElementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TradeAndOtherAccountsReceivablePolicy":  {
                "auth_ref":  [
                    "r139",
                    "r140",
                    "r141",
                    "r142",
                    "r143",
                    "r145"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for accounts receivable.",
                            "label":  "Accounts Receivable"
                            }
                        }
                    },
                "localname":  "TradeAndOtherAccountsReceivablePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain":  {
                "auth_ref":  [
                    "r146",
                    "r147",
                    "r148",
                    "r149",
                    "r150",
                    "r221",
                    "r249",
                    "r341",
                    "r376",
                    "r377",
                    "r378",
                    "r379",
                    "r380",
                    "r381",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r388",
                    "r389",
                    "r390",
                    "r391",
                    "r392",
                    "r393",
                    "r394",
                    "r395",
                    "r396",
                    "r397",
                    "r398",
                    "r399",
                    "r400",
                    "r401",
                    "r402",
                    "r403",
                    "r404",
                    "r405",
                    "r475",
                    "r476",
                    "r477",
                    "r478",
                    "r479",
                    "r480",
                    "r481"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
                            }
                        }
                    },
                "localname":  "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TypeOfArrangementAxis":  {
                "auth_ref":  [
                    "r333"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
                            }
                        }
                    },
                "localname":  "TypeOfArrangementAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative",
                    "http://biopowercorp.com/role/OrganizationDetailsNarrative",
                    "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative",
                    "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r110",
                    "r111",
                    "r113",
                    "r114",
                    "r118",
                    "r119",
                    "r120"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r93",
                    "r100"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted average common shares outstanding: basic and diluted"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://biopowercorp.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "sharesItemType"
                }
            },
        "unitCount":  5
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "270",
        "URI":  "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(20))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(3)(a)(4))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/topic&trid=2126998"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "410",
        "URI":  "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/topic&trid=2144648"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q4)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/topic&trid=2127136"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/topic&trid=2122149"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(f)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(i)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69B",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69C",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69E",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/topic&trid=2208564"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a)(5))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/topic&trid=2208762"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/topic&trid=49130388"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19,20)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(04)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(v)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.D.2.Q6)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "30",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/topic&trid=2228938"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(2))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "30",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "30",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "808",
        "URI":  "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/topic&trid=2197479"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(1)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(4)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(2)",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-30)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/topic&trid=2122745"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/topic&trid=2122774"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)(i)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)(ii)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(4)(i)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(4)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(5)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(6)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(7)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(b)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "330",
        "Topic":  "912",
        "URI":  "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(1)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(2)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(13))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r423":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(16))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r424":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r425":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(5))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r426":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r427":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r428":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r429":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
        },
    "r430":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Subparagraph":  "(a)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
        },
    "r431":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
        },
    "r432":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16)(a)(2))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r433":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r434":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r435":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r436":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r437":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r438":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r439":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r440":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.15(a))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r441":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.17)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r442":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r443":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r444":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4H",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
        },
    "r445":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
        },
    "r446":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
        },
    "r447":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(c)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
        },
    "r448":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
        },
    "r449":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r450":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r451":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r452":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r453":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r454":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
        },
    "r455":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
        },
    "r456":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "440",
        "Subparagraph":  "(a)",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
        },
    "r457":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(c)",
        "Topic":  "976",
        "URI":  "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
        },
    "r458":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "978",
        "URI":  "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
        },
    "r459":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r460":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r461":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r462":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-23"
        },
    "r463":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r464":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "g"
        },
    "r465":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12, 13, 15d"
        },
    "r466":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13e",
        "Subsection":  "4c"
        },
    "r467":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "14d",
        "Subsection":  "2b"
        },
    "r468":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "15",
        "Subsection":  "d"
        },
    "r469":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "14a",
        "Subsection":  "12"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.8)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r470":  {
        "Name":  "Form 10-K",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "310"
        },
    "r471":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r472":  {
        "Name":  "Form 20-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "220",
        "Subsection":  "f"
        },
    "r473":  {
        "Name":  "Form 40-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "240",
        "Subsection":  "f"
        },
    "r474":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r475":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(a)",
        "Publisher":  "SEC",
        "Section":  "1402"
        },
    "r476":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(1)"
        },
    "r477":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)"
        },
    "r478":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(3)"
        },
    "r479":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(i)"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r480":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(ii)"
        },
    "r481":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(iii)"
        },
    "r482":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r483":  {
        "Name":  "Securities Act",
        "Number":  "230",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r484":  {
        "Name":  "Securities Act",
        "Number":  "230",
        "Publisher":  "SEC",
        "Section":  "425"
        },
    "r485":  {
        "Name":  "Securities Act",
        "Number":  "7A",
        "Publisher":  "SEC",
        "Section":  "B",
        "Subsection":  "2"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(c))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(f))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(k)(1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.12-04(a))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/topic&trid=2122369"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "55",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
        }
    },
"version":  "2.1"
}

Top
Filing Submission 0001493152-22-034278   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 8:09:54.4pm ET